Redhawk Wealth Advisors’s aTyr Pharma ATYR Stock Holding History

Redhawk Wealth Advisors’s Portfolio ATYR Stock Details ATYR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-49,150	Closed	-$38.3K	–	459
2026 Q1	$38.3K	Buy	+49,150	New	+$41.5K	﹤0.01%	386

Other funds holding ATYR

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Trust Company of Toledo Holland, Ohio $1.2B AUM 33.38% 1-Year Est. Return

Ares Financial Consulting Calabasas, California $139M AUM

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Redhawk Wealth Advisors's ATYR Position: Q2 2026 in Review

Redhawk Wealth Advisors sold out of aTyr Pharma (ATYR) in Q2 2026, closing a stake of 49,150 shares — an estimated $38.3K sold.

Redhawk Wealth Advisors first reported a position in ATYR in Q1 2026 and held it in 1 quarter. The position peaked at $38.3K in Q1 2026. 10 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

Redhawk Wealth Advisors reported no remaining aTyr Pharma position as of Q2 2026 after selling out during the quarter.
Redhawk Wealth Advisors sold 49,150 aTyr Pharma shares in Q2 2026, an estimated $38.3K.
Redhawk Wealth Advisors first reported a position in aTyr Pharma in Q1 2026 and held it in 1 quarter.
Redhawk Wealth Advisors's aTyr Pharma position peaked at $38.3K in Q1 2026.
10 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on Redhawk Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.